CHADS2-VASc vs HAS-BLED
How to tell CHADS2-VASc and HAS-BLED apart when a board question makes them look alike.
Step 2 CK pairs are in open beta while clinical review finishes. Spot an issue? Tell us.
Use CHA2DS2-VASc to decide whether to anticoagulate, then use HAS-BLED to reduce bleeding risk while treating.
Side by side
CHA2DS2-VASc estimates thromboembolic stroke risk in atrial fibrillation and guides whether anticoagulation should be started.
HAS-BLED estimates major bleeding risk during anticoagulation and guides risk mitigation, not automatic withholding of anticoagulants.
Comorbid vascular and structural risk factors increase left atrial thrombus formation and embolic stroke probability.
Bleeding risk rises with uncontrolled hypertension, renal or liver dysfunction, prior bleeding, labile INR, age, and interacting drugs or alcohol.
CHA2DS2-VASc scoring includes congestive heart failure, hypertension, age 65 to 74 (1 point) or at least 75 (2 points), diabetes, stroke or TIA history (2 points), vascular disease, and sex category; anticoagulation is generally recommended for men with score at least 2 or women with score at least 3.
HAS-BLED uses hypertension above 160 mm Hg systolic, abnormal renal or liver function, stroke history, bleeding history, labile INR, age above 65, and drugs or alcohol; score at least 3 indicates high bleeding risk needing closer follow-up and correction of modifiable factors.
The trap
A common mistake is withholding anticoagulation solely because HAS-BLED is high despite very high stroke risk. High HAS-BLED should prompt blood pressure control, medication review, and monitoring rather than reflex denial of stroke prevention.
The repair move
Next best step: calculate CHA2DS2-VASc first and start oral anticoagulation when stroke risk threshold is met, usually with a direct oral anticoagulant unless contraindicated. Then calculate HAS-BLED to identify modifiable bleeding risks such as uncontrolled blood pressure, interacting medications, and renal function issues, and schedule closer follow-up rather than withholding indicated anticoagulation.
Try a free question
CoreA 72-year-old woman with atrial fibrillation has hypertension, diabetes, and prior ischemic stroke. What is the next best step in management?
Show answer and explanation
Answer: A. Start anticoagulation based on high CHA2DS2-VASc stroke risk. Very high CHA2DS2-VASc score indicates clear need for anticoagulation to prevent embolic stroke.
Why the other choices are tempting
- B. HAS-BLED is not a standalone tool to deny indicated stroke prevention.
- C. Aspirin alone is inadequate stroke prevention for high-risk AF.
- D. No therapy leaves substantial preventable embolic risk.
- E. Rhythm strategy does not replace anticoagulation risk assessment.
Flashcards
Tap a card to flip it.
Which atrial fibrillation score determines whether anticoagulation should be initiated?
CHA2DS2-VASc is used to estimate stroke risk and decide on anticoagulation initiation.
What is the main purpose of HAS-BLED after deciding anticoagulation need?
HAS-BLED estimates bleeding risk and helps target modifiable risk reduction and monitoring intensity.
Quick answers
What is the fastest way to tell CHADS2-VASc from HAS-BLED?
Use CHA2DS2-VASc to decide whether to anticoagulate, then use HAS-BLED to reduce bleeding risk while treating.
What is the key clue for CHADS2-VASc?
CHA2DS2-VASc estimates thromboembolic stroke risk in atrial fibrillation and guides whether anticoagulation should be started.
What is the key clue for HAS-BLED?
HAS-BLED estimates major bleeding risk during anticoagulation and guides risk mitigation, not automatic withholding of anticoagulants.
What is the common trap with CHADS2-VASc vs HAS-BLED?
A common mistake is withholding anticoagulation solely because HAS-BLED is high despite very high stroke risk. High HAS-BLED should prompt blood pressure control, medication review, and monitoring rather than reflex denial of stroke prevention.